6-Chloro-N'-(5-chloro-2-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide

ID: ALA4568499

PubChem CID: 145999855

Max Phase: Preclinical

Molecular Formula: C17H10Cl2N2O5

Molecular Weight: 393.18

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NNC(=O)c1cc2cc(Cl)ccc2oc1=O)c1cc(Cl)ccc1O

Standard InChI:  InChI=1S/C17H10Cl2N2O5/c18-9-2-4-14-8(5-9)6-12(17(25)26-14)16(24)21-20-15(23)11-7-10(19)1-3-13(11)22/h1-7,22H,(H,20,23)(H,21,24)

Standard InChI Key:  HZBQVEFZUKLVDD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   15.8802  -19.6703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8790  -20.4899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5871  -20.8988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5853  -19.2615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2939  -19.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2927  -20.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0028  -20.9033    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7186  -20.4940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7198  -19.6688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0052  -19.2529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4252  -20.9046    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4285  -19.2619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1352  -19.6722    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4305  -18.4447    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8439  -19.2654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5506  -19.6757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2594  -19.2688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5486  -20.4929    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.9625  -19.6817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6707  -19.2755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6731  -18.4574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9614  -18.0472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2561  -18.4558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9583  -20.4988    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.9605  -17.2300    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.1724  -19.2619    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  8 11  2  0
  9 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 17  1  0
 19 24  1  0
 22 25  1  0
  1 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4568499

    ---

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 integrase (9041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.18Molecular Weight (Monoisotopic): 391.9967AlogP: 2.88#Rotatable Bonds: 2
Polar Surface Area: 108.64Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 7.53CX Basic pKa: CX LogP: 3.38CX LogD: 3.14
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.46Np Likeness Score: -0.92

References

1. Jesumoroti OJ, Faridoon, Mnkandhla D, Isaacs M, Hoppe HC, Klein R..  (2019)  Evaluation of novel N'-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors.,  10  (1): [PMID:30774857] [10.1039/C8MD00328A]

Source